Quantify Technology Holdings quick to demonstrate revenue pipeline

Published 17-MAR-2017 15:07 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Despite only recently commencing trading on the ASX (March 8), Quantify Technology (ASX: QFY) has been quick to articulate its strategy and announce material revenue earning contracts. This sets it apart from many peers in the Internet of Things space where some companies find it difficult to even define their revenue model, let alone provide any confidence regarding near-term income visibility.

Consequently, today’s announcement that the group’s products have been specified for two projects in Western Australia and one in New South Wales, as well as having a significant involvement in a major South Australian property development venture should provide further share price momentum.

Of course this is an early stage play and any share price momentum is speculative, so investors should seek professional financial advice if considering this stock for their portfolio.

As a backdrop, QFY’s technology platform encompasses a range of products that provide clients with a distribution platform for the future evolution of Internet of Things technologies. These include retrofittable switches and power outlets designed to provide real-time evaluation of environmental and risk factors for building occupants.

The group assists in managing services and utilities in order to optimise efficiencies, effectively creating ‘Truly Intelligent Buildings’. Included within each device is autonomous compute power allowing the delivery of advanced applications without the dependency on “Cloud Computing” applications or local gateways or servers.

Q Device to be used in three new property projects

QFY advised today that the Q Device has been included in the building specifications for three projects, two in Western Australia and one in New South Wales.

The two Western Australian projects are a medical and dental library and the Crest Apartment project in Burswood. The New South Wales project relates to the Lindfield Apartments in Sydney.

The Q Device has been specified for use in the electrical engineering plans for the projects. While firm contracts are yet to be negotiated, the specification of the devices represents an endorsement from both building contractors and electrical consultants.

QFY products to be exclusively used in $220 million Wallaroo Shores project

Further to this development, QFY announced that construction work on the Wallaroo Shores project is expected to start in May. The group had previously signed an agreement with developer Copper Coast Investments for the sale and installation of its products for approximately 650 dwellings.

Wallaroo Shores is an 18.5 hectare development valued at $220 million and will feature a four-star resort, a residential component, a lifestyle village, and a commercial and retail sector.

Copper Coast has agreed to exclusively promote and procure the purchase and installation of QFY’s products in buildings erected at Wallaroo Shores by incorporating a requirement that the owners use QFY’s products for dwellings erected as part of the project.

Commenting on the group’s outlook, Managing Director, Mark Lapins said “We continue to receive strong interest from property developers across a number of major Australian cities to supply our products into commercial and large residential projects”.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X